FDA approves patch to treat depression in adults

02/28/2006 | MSNBC

The FDA has approved Emsam, a selegiline transdermal patch to treat depression in adults, but the drug will have to carry a black-box warning for suicide. The patch is a product of Bristol-Myers Squibb and Somerset Pharmaceuticals, which is a joint venture between Mylan Laboratories and Watson Pharmaceuticals.

View Full Article in:

MSNBC

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Executive Officer
UCare Minnesota
Minneapolis, MN